Citation: Wj. Ray et al., MOLECULAR PATHOGENESIS OF SPORADIC AND FAMILIAL FORMS OF ALZHEIMERS-DISEASE, Molecular medicine today, 4(4), 1998, pp. 151-157
Citation: C. Chavany et M. Jendoubi, BIOLOGY AND POTENTIAL STRATEGIES FOR THE TREATMENT OF G(M2) GANGLIOSIDES, Molecular medicine today, 4(4), 1998, pp. 158-165
Citation: C. Lengauer et Jp. Issa, THE ROLE OF EPIGENETICS IN CANCER - DNA METHYLATION, IMPRINTING AND THE EPIGENETICS OF CANCER - AN AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCHSPECIAL CONFERENCE - LAS-CROABAS, PUERTO-RICO, 12-16 1997 DECEMBER, Molecular medicine today, 4(3), 1998, pp. 102-103
Citation: S. Abdulla, TUBERCULOSIS - MILKING THE GENOME FOR DRUG TARGETS AND VACCINES - NOVARTIS-FOUNDATION-SYMPOSIUM - GENETICS AND TUBERCULOSIS - CAPE-TOWN, SOUTH-AFRICA, 18-20 NOVEMBER 1997, Molecular medicine today, 4(3), 1998, pp. 104-105
Citation: Dh. Sachs, BRUSHING UP ON IMMUNOLOGICAL-TOLERANCE - IMMUNOLOGICAL-TOLERANCE FOR IMMUNE-SYSTEM MEDIATED DISEASES, BETHESDA, MD, USA, 8 DECEMBER 1997, Molecular medicine today, 4(3), 1998, pp. 105-106
Citation: C. Exley, DOES ANTIPERSPIRANT USE INCREASE THE RISK OF ALUMINUM-RELATED DISEASE, INCLUDING ALZHEIMERS-DISEASE, Molecular medicine today, 4(3), 1998, pp. 107-109
Citation: Im. Morison et Ae. Reeve, INSULIN-LIKE-GROWTH-FACTOR-2 AND OVERGROWTH - MOLECULAR-BIOLOGY AND CLINICAL IMPLICATIONS, Molecular medicine today, 4(3), 1998, pp. 110-115
Citation: N. Zavazava, SOLUBLE HLA CLASS-I MOLECULES - BIOLOGICAL SIGNIFICANCE AND CLINICAL IMPLICATIONS, Molecular medicine today, 4(3), 1998, pp. 116-121
Citation: T. Cawson, MATRIX METALLOPROTEINASES AND TIMPS - PROPERTIES AND IMPLICATIONS FORTHE RHEUMATIC DISEASES, Molecular medicine today, 4(3), 1998, pp. 130-137
Citation: C. Macdonald, ANIMAL-CELL TECHNOLOGY FOR NEW HEALTH-CARE PRODUCTS - 15TH EUROPEAN-SOCIETY FOR ANIMAL-CELL TECHNOLOGY (ESACT) MEETING - TOURS, FRANCE, 7-11 SEPTEMBER 1997, Molecular medicine today, 4(2), 1998, pp. 54-55
Citation: K. Wood, TRANSPLANTATION BIOLOGY - RECENT ADVANCES - 5TH BASIC SCIENCES SYMPOSIUM OF THE TRANSPLANTATION-SOCIETY - CHAUTAUQUA, NY, USA, 6-11 SEPTEMBER 1997, Molecular medicine today, 4(2), 1998, pp. 56-57
Citation: S. Strand et Pr. Galle, IMMUNE EVASION BY TUMORS - INVOLVEMENT OF THE CD95 (APO-1 FAS) SYSTEMAND ITS CLINICAL IMPLICATIONS/, Molecular medicine today, 4(2), 1998, pp. 63-68